1. Introduction {#sec1-biomolecules-09-00828}
===============

Soybeans are an important food resource that has beneficial purposes as "meat in the field" because of its nutritional value \[[@B1-biomolecules-09-00828]\]. Presently, most Asian countries produce soybeans to use as food ingredients, feed additives, biomaterials, etc. \[[@B2-biomolecules-09-00828]\]. A high dietary intake of soybeans can reduce the risk of breast cancer and coronary heart disease and exerts anti-diabetic effects by enhancing glucose uptake \[[@B3-biomolecules-09-00828],[@B4-biomolecules-09-00828],[@B5-biomolecules-09-00828]\]. Soybeans contain phytoalexin compounds, such as glyceollin, genistein, luteolin, and daidzein. Phytoalexins include isoflavones which are induced by plant defense mechanisms against soil pathogens, such as bacteria and fungi \[[@B6-biomolecules-09-00828]\]. Phytoalexins are also produced when soybeans are exposed to various stresses, such as microbes, ultraviolet light, and other physical attacks \[[@B7-biomolecules-09-00828]\]. Soybean-derived polyphenol compounds are known to exert antioxidant, antitumor, anti-inflammatory, anti-obesity, and anti-atopic effects \[[@B8-biomolecules-09-00828],[@B9-biomolecules-09-00828],[@B10-biomolecules-09-00828]\].

Glyceollins, which are synthesized from daidzein in soybeans infected with fungi, are potent antioxidants that inhibit the production of reactive oxygen species (ROS) \[[@B11-biomolecules-09-00828]\]. Glyceollins also display anti-inflammatory effects by suppressing the nuclear factor kappa B (NF-κB) signaling pathway \[[@B12-biomolecules-09-00828]\]. Glyceollins not only exert antitumor effects by inhibiting angiogenesis, but also have antimelanogenic activity by reducing melanin biosynthesis \[[@B13-biomolecules-09-00828],[@B14-biomolecules-09-00828]\]. Daidzein is converted into glyceollin in soybeans during fermentation after infection by a fungus such as *Aspergillus sojae*. However, data on the enzymatic effects of glyceollins derived from phytoalexins and studies on how glyceollins and other anti-diabetic agents are involved in the inhibition of *α*-glucosidase are lacking.

The enzyme α-glucosidase (EC 3.2.1.20; alternatively named maltase, glucoinvertase, glucosidosucrase, maltase-glucoamylase, α-glucopyranosidase, glucosido-invertase, α-D-glucosidase, α-glycoside hydrolase, α-1,4-glucosidase, or α-D-glucoside glucohydrolase) catalyzes the exohydrolysis of 1,4-α-glucosidic linkages, and hydrolyzes oligosaccharides rapidly relative to polysaccharides \[[@B15-biomolecules-09-00828]\]. The enzyme hydrolyzes terminal, non-reducing (1 → 4)-linked α-glucose residues to release a single α-glucose molecule. The substrate selectivity of α-glucosidase is due to the substrate affinity for the active site of the enzyme \[[@B16-biomolecules-09-00828]\]. In individuals with type 2 diabetes, α-glucosidase induces postprandial hyperglycemia by breaking di-, tri-, and oligosaccharides into monosaccharides, and α-glucosidase inhibitors delay carbohydrate digestion and absorption, thereby attenuating postprandial hyperglycemia \[[@B17-biomolecules-09-00828]\]. The anti-diabetic potential of α-glucosidase inhibition has been seen with *p*-nitrophenyl α-D-glucopyranoside (pNPG), and there is mounting evidence that various α-glucosidase inhibitors produced by plants such as legumes also exert anti-diabetic effects \[[@B18-biomolecules-09-00828],[@B19-biomolecules-09-00828],[@B20-biomolecules-09-00828]\].

In the present study, we first compared the ability of four polyphenol compounds (glyceollin, genistein, luteolin, and daidzein) derived from soybeans to inhibit α-glucosidase, and then studied the inhibitory mechanism of action by calculating the *K~i~* values of the four polyphenol compounds. We also investigated the synergistic effects between glyceollin and the other three polyphenol compounds. A deeper understanding of the enzyme kinetics and mode of action of glyceollin could help to develop nutraceuticals that prevent diabetes without side effects. Our results indicate that a combination of glyceollin and luteolin has synergistic effects on α-glucosidase inhibition.

2. Materials and Methods {#sec2-biomolecules-09-00828}
========================

2.1. Reagents {#sec2dot1-biomolecules-09-00828}
-------------

α-Glucosidase (from baker's yeast; \#63231-63-0; EC:3.2.1.20), pNPG, acarbose (≥95%), genistein (≥98%), daidzein (≥98%), and luteolin (≥98%) were purchased from Sigma-Aldrich (St, Louis, MO, USA). Glyceollin, which has three isomers, was semi-purified from elicited soybeans, as described previously \[[@B21-biomolecules-09-00828]\]. All reagents were of analytical grade and prepared at various concentrations by dissolution in dimethyl sulfoxide (DMSO), except for water-soluble acarbose. The structures of the compounds are shown in [Figure 1](#biomolecules-09-00828-f001){ref-type="fig"}.

2.2. Inhibition of α-glucosidase {#sec2dot2-biomolecules-09-00828}
--------------------------------

The activity of α-glucosidase was measured as described previously, with slight modifications \[[@B22-biomolecules-09-00828]\]. In brief, sodium phosphate buffer (0.1 M) was adjusted to 0.1 N HCl to pH 7.0 with a pH meter (Thermo Fisher Scientific Inc., Waltham, MA, USA). Solutions of pNPG (10 mM) and α-glucosidase (1 U/mL) were solubilized in 0.1 M sodium phosphate buffer (pH 7.0). All reagents were prepared shortly before use and warmed to 37 °C in a water bath (Il-shin Biobase, Pocheon, Korea). Polyphenols (1--30 μM) and acarbose (100--3000 μM, A8980, Sigma) were placed in a 96-well plate. The substrate, pNPG (N1377, Sigma), was added into each well to a final concentration of 1 mM in a total volume of 200 μL, and 100 μL of α-glucosidase (1 U/mL) per well was then added. The absorbance at 405 nm was measured immediately using a spectrophotometer (Victor3 multi-label counter, Wallac, Turku, Finland) at 37 °C and then every 2 min for 40 min. The absorbance values were plotted against time, and the rate (velocity) of product generation (α-glucosidase activity) was calculated from the linear range of the graph.

2.3. Enzyme Kinetics for α-glucosidase {#sec2dot3-biomolecules-09-00828}
--------------------------------------

The enzyme reaction was performed according to the above reaction conditions with polyphenols at various concentrations (1--30 μM). pNPG (1 mM) was added with polyphenols in 96-well plates, and α-glucosidase (1 U/mL) was added to initiate the enzyme reaction. The absorbances for each concentration of pNPG were then obtained by spectrophotometry (Victor3, PerkinElmer, Waltham, MA, USA). The inhibition modes of the polyphenols were determined using Michaelis--Menten and Lineweaver--Burk equations \[[@B23-biomolecules-09-00828],[@B24-biomolecules-09-00828]\]. The inhibition constant *K~i~* is an indication of the potency of an inhibitor and equals the concentration required to produce half-maximal inhibition and can be determined by a Dixon plot \[[@B25-biomolecules-09-00828]\]. To describe how these agents inhibit α-glucosidase, Lineweaver--Burk equations, in double reciprocal form, are expressed as follows: $\frac{1}{v} = \ \frac{Km}{Vmax}\ \left( {1 + \frac{1}{Ki}} \right) \times \frac{1}{\left\lbrack S \right\rbrack} + \frac{1}{Vmax}\ $(Competitive inhibition)$\frac{1}{v} = \ \frac{Km}{Vmax}\  \times \ \frac{1}{\left\lbrack S \right\rbrack}\  + \ \frac{1}{Vmax}\left( {1 + \frac{\left\lbrack I \right\rbrack}{Ki}} \right)\ $(Uncompetitive inhibition)$\frac{1}{v} = \ \frac{Km}{Vmax}\  \times \left( {1\  + \ \frac{\left\lbrack I \right\rbrack}{Ki}} \right)\  \times \ \frac{1}{\left\lbrack S \right\rbrack}\  + \ \frac{1}{Vmax}\left( {1 + \frac{\left\lbrack I \right\rbrack}{Ki}} \right)\ $(Noncompetitive inhibition)$\frac{1}{v} = \ \frac{Ks}{Vmax}\left( {1 + \frac{\left\lbrack I \right\rbrack}{Ki}} \right) \times \frac{1}{\left\lbrack S \right\rbrack} + \frac{1}{Vmax}\left( {1 + \frac{\left\lbrack I \right\rbrack}{\alpha Ki}} \right)\ $(Mixed inhibition) where *v* is the enzyme reaction rate in the absence and presence of inhibitors or polyphenol compounds; *V~max~* and \[*S*\] are the maximum reaction velocity and the substrate concentration, respectively; and *K~m~* and *K~s~* are the Michaelis--Menten and dissociation constants for the affinity of the substrate, respectively. The *α* symbol is the ratio of the uncompetitive inhibition constant to the competitive inhibition constant and has a value of 1 for noncompetitive inhibition. The *αK~i~* value is the inhibitor constant when the inhibitor (I) occupies the enzyme--substrate (ES) complex \[[@B25-biomolecules-09-00828]\].

2.4. Docking Studies {#sec2dot4-biomolecules-09-00828}
--------------------

To investigate the modes of α-glucosidase inhibition for individual polyphenols, docking calculations were performed by Autodock Vina software, a program that simulates molecular docking and virtual screening, which is improved compared to the average accuracy of the binding mode predictions of AutoDock 4.0 \[[@B26-biomolecules-09-00828]\]. Three-dimensional coordinates of α-glucosidase used as the input structure were prepared by modeling using the SWISS-MODEL server \[[@B27-biomolecules-09-00828]\]. The protein modeling used the structure of isomaltase from *Saccharomyces cerevisiae* (PDB code 3AJ7) as a template, having 73% amino acid identity with the commercial α-glucosidase, MAL12. For the docking calculation, the generation of the *pdbqt* files and determination of the grid box size were done with AutoDock Tools, Version 1.5.4 software (<http://mgltools.scripps.edu/>). Default parameters, except the exhaustiveness option, were used as described in the AutoDock Vina manual. The side chain of residues (Asp68, Tyr71, His111, Phe151, Phe177, Arg212, Asp214, Thr215, His239, Glu276, His279, Phe300, Arg312, His348, Asp349, and Arg439) were allowed to rotate and an active site defined by a grid box was centered at x = 17.471, y = −7.312, and z = 21.611 with size of 46 × 36 × 48 Å (0.375 spacing). Nine output poses were generated and evaluated by their calculated free energy of binding. The best theoretical binding mode of each inhibitor was selected by its ΔG~bind~ score.

2.5. Synergistic Effects on α-glucosidase Inhibition {#sec2dot5-biomolecules-09-00828}
----------------------------------------------------

Synergistic effects on α-glucosidase inhibition were measured using the same methods as above. A designated concentration (0.5--2.0 mM) of pNPG, together with a combination of two polyphenols, was added to a 96-well plate, and the enzyme reaction was initiated by the addition of α-glucosidase (1 U/mL). We calculated the IC~50~ values of each polyphenol and the combinations, and we used the statistical differences of these values to assess synergistic effects.

2.6. Determination of the Combination Index (CI) {#sec2dot6-biomolecules-09-00828}
------------------------------------------------

CI values were calculated by the method of Chou \[[@B28-biomolecules-09-00828]\], which offers a theoretical basis for the CI--isobologram equation that permits the quantitative determination of compound interactions. Based on the algorithm, computer software has been established to simulate synergism and antagonism at any ratio. In brief, the derived CI equation for two compounds is: where (Dx)1 for (D)1 "alone" that inhibits a system x%, and (Dx)2 for (D)2 "alone" that inhibits a system x% whereas in the numerator, (D)1 + (D)2, "in combination" also inhibit x%. Note that the denominators of the last two terms are expressed as median effects. The CI value quantitatively defines synergism (CI \< 1), an additive effect (CI = 1), and antagonism (CI \> 1).

In single drug dynamics, the equation is defined as fa/fu = \[D/Dm\]^m^, where fa is the affected fraction of the system and fu is the unaffected fraction (fu = 1 − fa); D is the dose required to produce fa; Dm is the dose required to produce median effects, such as ED~50~ or IC~50~; and m is sigmoidicity (shape).

2.7. Statistical Analysis {#sec2dot7-biomolecules-09-00828}
-------------------------

The results are presented as the mean ± standard deviation (SD) of experiments performed in triplicate. Statistical differences were determined by Tukey's one-way ANOVA using IBM SPSS software (Armonk, NY, USA). A difference was considered significant at *p* \< 0.05.

3. Results {#sec3-biomolecules-09-00828}
==========

3.1. Potential of Phytoalexins Derived from Soybeans to Inhibit α-Glucosidase {#sec3dot1-biomolecules-09-00828}
-----------------------------------------------------------------------------

The ability of polyphenol compounds derived from soybeans to inhibit α-glucosidase ([Figure 1](#biomolecules-09-00828-f001){ref-type="fig"}B--E) was measured to identify which compound is most effective. Acarbose ([Figure 1](#biomolecules-09-00828-f001){ref-type="fig"}A) is an anti-diabetic drug \[[@B19-biomolecules-09-00828]\] and was used as a positive control in the α-glucosidase inhibition assays \[[@B29-biomolecules-09-00828]\]. All compounds tested reduce α-glucosidase activity in a concentration-dependent manner ([Figure 1](#biomolecules-09-00828-f001){ref-type="fig"}F, grey columns). The half-maximal inhibitory concentrations (IC~50~) of acarbose, glyceollin, genistein, luteolin, and daidzein were 530.50 ± 100.13 μM, 13.22 ± 2.31 μM, 23.66 ± 3.54 μM, 11.94 ± 1.63 μM, and 20.16 ± 6.17 μM, respectively. These results show that the four soybean-derived polyphenol compounds exert α-glucosidase inhibitory activity that is more than 20 times higher than that of acarbose.

3.2. Determination of Inhibition Modes and K~i~ Values on Polyphenols Derived from Soybeans on α-glucosidase {#sec3dot2-biomolecules-09-00828}
------------------------------------------------------------------------------------------------------------

To define the mode of inhibition of the polyphenols, enzyme kinetics were performed with designated concentrations of pNPG. The maximum velocity (V~max~) for α-glucosidase was calculated from the nonlinear regression curve with five different concentrations of substrate ([Figure 2](#biomolecules-09-00828-f002){ref-type="fig"}). To determine the inhibition modes, Lineweaver--Burk plots were constructed for each of the inhibition modes, and the most suitable mode was selected using SigmaPlot 10.0 software. The results reveal that the mode of acarbose and glyceollin inhibition is competitive, while that of genistein is noncompetitive. Luteolin shows mixed inhibition modes, and the mode of daidzein inhibition is uncompetitive ([Figure 3](#biomolecules-09-00828-f003){ref-type="fig"}).

Meanwhile, the inhibitor constant *K~i~* indicates the potency of an inhibitor and is expressed as the concentration required to produce half-maximal inhibition and is determined by a Dixon plot \[[@B25-biomolecules-09-00828]\]. The initial slope *v* was determined for each concentration of each polyphenol. The reciprocal velocity (1/*v*) versus the substrate concentration (for 0.25, 0.5, 1, and 2 mM pNPG) was plotted. A single regression line for each concentration of the substrate was obtained, and *K~i~* was calculated from the intersection of the four lines. The *K~i~* values were determined by GraphPad Prism 6.0 software as 45.88 ± 3.75 μM, 18.99 ± 4.45 μM, 15.42 ± 2.48 μM, and 16.81 ± 9.60 μM, for acarbose, glyceollin, genistein, and luteolin, respectively ([Table 1](#biomolecules-09-00828-t001){ref-type="table"}). It is not possible to calculate *K~i~* in the case of uncompetitive inhibition because the four lines do not intersect. Therefore, for daidzein, the *αK~i~* value was calculated; the *αK~i~* constant is the inhibitor constant when an inhibitor occupies the enzyme--substrate complex. The *αK~i~* value of daidzein was calculated as 9.99 ± 1.24 μM.

3.3. Structural Bases for the Modes of Inhibition {#sec3dot3-biomolecules-09-00828}
-------------------------------------------------

To understand the modes of inhibition at a molecular level, we performed docking studies using the structure-guided model of α-glucosidase. Docking models of acarbose, glyceollin, genistein, luteolin, and daidzein were generated, and the best models of each inhibitor were chosen ([Figure 4](#biomolecules-09-00828-f004){ref-type="fig"}A--E). First, we compared the docking model of acarbose with the homologous structure complexed with maltose. The superimposition reveals that acarbose is docked into the pocket in which the substrate isomaltose binds experimentally, and a nitrogen atom is located near the glycosidic bond of the substrate to block hydrolysis ([Figure 4](#biomolecules-09-00828-f004){ref-type="fig"}A). The result explains why the acarbose competitively binds to α-glucosidase and inhibits the enzyme. We then used the acarbose model as an indicator of the substrate-binding site, onto which the other docking models were superimposed.

The α-glucosidase is applied to the docking model of glyceollin, which is a pterocarpan that is structurally different from other isoflavones and flavone, with its substrate-binding pocket ([Figure 4](#biomolecules-09-00828-f004){ref-type="fig"}B). The theoretical binding affinity (ΔG~bind~) is −10.3 kcal/mol. This structural model illustrates the competitive inhibition of glyceollin. Although the polyphenols tested are similar in structure, they dock in the active site pocket with different orientations. Interestingly, the model with daidzein shows that the substrate covers the entrance of the pocket with a ΔG~bind~ of −7.6 kcal/mol ([Figure 4](#biomolecules-09-00828-f004){ref-type="fig"}E). Although an uncompetitive inhibitor binds only to the enzyme--substrate complex, the relative affinity of the binding compared to that of glyceollin might be lower. Consequently, the model shows the binding cavity of the uncompetitive inhibitor and might explain the rare uncompetitive inhibition mode as described above. Luteolin and genistein are proposed to be mixed and noncompetitive inhibitors, respectively. A mixed inhibitor binds both the apoenzyme and the enzyme--substrate complex, and it binds a different site than the substrate-binding pocket, altering the active-site configuration and the enzymatic turnover. Noncompetitive inhibition is a special case of mixed inhibition under an unchanged *K~m~*. Surprisingly, the docking models show a different cavity that harbors luteolin and genistein with ΔG~bind~ values of −8.4 and −8.7 kcal/mol, respectively, intimating that noncompetitive or mixed inhibition might occur by altering the catalytic cleft upon attachment ([Figure 4](#biomolecules-09-00828-f004){ref-type="fig"}C,D).

3.4. Combined Effects of Glyceollin Plus Luteolin on α-glucosidase Inhibition {#sec3dot4-biomolecules-09-00828}
-----------------------------------------------------------------------------

We studied the α-glucosidase inhibitory effect of pairs of polyphenols by mixing glyceollin with luteolin, genistein, or daidzein. As shown in [Table 2](#biomolecules-09-00828-t002){ref-type="table"}, we obtained IC~50~ values for each polyphenol singly and the combination treatments on α-glucosidase inhibition at each concentration of pNPG. Interestingly, luteolin shows a combined effect on α-glucosidase inhibition when combined with glyceollin. However, neither genistein nor daidzein shows a combined effect ([Table 2](#biomolecules-09-00828-t002){ref-type="table"}, bold characters).

We further investigated these combined effects of glyceollin and luteolin by making mixtures in ratios ranging from 0:10 to 10:0 and then testing their inhibition of *α*-glucosidase. The results show that a 3:7 ratio of glyceollin to luteolin causes the highest inhibition of *α*-glucosidase. We then plotted the kinetic modes of action in [Figure 5](#biomolecules-09-00828-f005){ref-type="fig"}B. Surprisingly, the data show that the mode of action is competitive inhibition. These results indicate that a combination of competitive and mixed inhibition modes might exert more potent inhibition on α-glucosidase activity, whereas a combination of competitive and uncompetitive or noncompetitive modes are less potent.

3.5. Confirmation of Synergism by CI Equation with Glyceollin Plus Luteolin {#sec3dot5-biomolecules-09-00828}
---------------------------------------------------------------------------

To scrutinize whether the inhibition mode of the combination of glyceollin and luteolin is synergistic, we calculated CI values for experimental data by the method of Chou \[[@B28-biomolecules-09-00828]\]. Four data points for glyceollin or luteolin (1, 3, 10, and 30 μM) were entered into the equation, and the resulting *K~m~* values were 13.6215 and 12.2697, respectively. As shown in [Figure 5](#biomolecules-09-00828-f005){ref-type="fig"}C, the ratios of glyceollin to luteolin between 9:1 to 7:3 show CI values \>1.0. The ratios of glyceollin to luteolin between 6:4 to 1:9 yield CI values \<1.0. Interestingly, the 3:7 ratio produces the lowest CI value, suggesting that this ratio ranks as having the most synergistic effect on *α*-glucosidase inhibition.

4. Discussion {#sec4-biomolecules-09-00828}
=============

In a study of α-glucosidase related to postprandial hyperglycemia in type 2 diabetes, glyceollin showed an effect similar to three known polyphenols (genistein, luteolin, and daidzein; [Table 1](#biomolecules-09-00828-t001){ref-type="table"}). To the best of our knowledge, this is the first time that glyceollin was revealed to be a competitive inhibitor of α-glucosidase ([Figure 3](#biomolecules-09-00828-f003){ref-type="fig"}B). Competitive and mixed inhibitors exert their effects by combining with free enzyme to prevent substrate binding, thus producing an enzyme--inhibitor (EI) complex. By contrast, noncompetitive or uncompetitive inhibitors cannot directly interrupt the binding of the enzyme to its substrate. We hypothesized that a synergistic effect would occur between competitive and noncompetitive (or uncompetitive) inhibitors because the binding sites of the inhibitors are different. However, combinations of competitive and noncompetitive (or uncompetitive) inhibitors decreased the inhibition activity ([Table 2](#biomolecules-09-00828-t002){ref-type="table"}). Interestingly, glyceollin (a competitive inhibitor) and luteolin (a mixed inhibitor) displayed a significant synergistic effect, with decreased IC~50~ values at all concentrations of the substrate ([Table 2](#biomolecules-09-00828-t002){ref-type="table"}).

General biological mechanisms are not limited to the reaction of a single compound. Therefore, complicated synergistic mechanisms are likely to be involved in many biological events in other investigations of mechanisms of α-glucosidase inhibition \[[@B30-biomolecules-09-00828]\]. Liu et al. demonstrated that a combination of inhibitors improves α-glucosidase inhibition \[[@B31-biomolecules-09-00828]\]. They selected two typical xanthone derivatives (1,3,7-trihydroxyxanthone and 1,3-dihydroxybenzoxanthone) and observed their synergistic effect. In their study, 2 μM of 1,3,7-trihydroxyxanthone exhibited approximately 15% inhibition, while 2 μM of 1,3-dihydroxybenzoxanthone exhibited approximately 10% inhibition. Interestingly, the synergistic effect of combining the two inhibitors at a 3:7 ratio produced a maximal inhibition of 40% \[[@B31-biomolecules-09-00828]\]. Another study on α-glucosidase demonstrated genistein synergistic inhibition when combined with metal ions such as copper and zinc \[[@B30-biomolecules-09-00828]\]. Therefore, we hypothesized that a mixture of two polyphenols would exert synergistic inhibition against α-glucosidase. Indeed, glyceollin showed a synergistic effect with luteolin on α-glucosidase inhibition ([Table 2](#biomolecules-09-00828-t002){ref-type="table"}). When acarbose, which is a competitive inhibitor like glyceollin, was used in combination with luteolin or glyceollin, no synergistic effects were observed. Combined treatment with genistein and daidzein also produced no synergistic effects.

It was shown that dose and effect are interchangeable via defined parameters derived from the unified theory for the Michaelis--Menten equation, Hill equation, Henderson--Hasselbalch equation, and Scatchard equation. These equations provide the theoretical basis for the combination index (CI)--isobologram equation that allows quantitative determination of compound interactions, where CI \< 1, CI = 1, and CI \> 1 denote synergism, an additive effect, and antagonism \[[@B28-biomolecules-09-00828]\], respectively. In this study, by applying a unique and effective systemic method, we disclosed that a combination of glyceollin (a competitive inhibitor) and luteolin (a mixed inhibitor) displayed a significant synergistic effect, with a decreased maximal CI value (0.64244) at a 3:7 ratio of glyceollin to luteolin, theoretically ([Figure 5](#biomolecules-09-00828-f005){ref-type="fig"}C). This theoretical approach can be applied to various studies in biomolecular sciences, from how to effectively evaluate an extract by food ingredient(s), to how to beneficially use multiple compounds, or modalities, in combination therapies for the development of nutraceuticals or functional biomolecules.

To verify whether the combination of glyceollin and luteolin affects the mode of α-glucosidase inhibition, it was necessary to analyze the affinity of each of the polyphenol compounds. When soybeans are infected with various elicitors, polyphenol compounds are naturally produced. Such polyphenol compounds are called phytoalexins, although the identification of the polyphenols is still needed. This study investigated the synergistic potency of two polyphenols by comparing their *K~i~* values; however, we do not know how the structure of the enzyme is changed by the binding of inhibitors. Therefore, it would be useful to perform molecular docking simulation studies and protein structure analyses, including X-ray crystallography and nuclear magnetic resonance (NMR), to determine the mode of synergistic inhibition of soybean-derived polyphenols, which will shed light on their inhibitory mechanisms.

5. Conclusions {#sec5-biomolecules-09-00828}
==============

By analyzing enzyme inhibition kinetics using Michaelis--Menten plots and Lineweaver--Burk plots, we found that inhibition mode of glyceollin was competitive inhibition, that of genistein was noncompetitive, that of daidzein was uncompetitive, and luteolin showed a mixed mode of action. These results indicate that glyceollin, genistein, luteolin, and daidzein could be promising α-glucosidase inhibitors for anti-diabetic approaches. A combination of glyceollin and luteolin had synergistic effects on *α*-glucosidase inhibition, showing that a combination of glyceollin and luteolin has the potential to inhibit *α*-glucosidase activity via a synergistic mode of action. The inhibition of α-glucosidase by polyphenol compounds from soybeans is not so high when the soybeans are not elicited by *Aspergillus*. However, the glyceollin produced by fermentation in response to *Aspergillus* or other fungi is thought to rapidly enhance the antidiabetic effect. Collectively, we believe that fermentation of soybeans induces various phytoalexins (e.g., glyceollins in soybeans); therefore, the intake of fermented soybeans in foods such as soy sauce, soy paste, Koji, and Natto might be useful to synergistically prevent and/or control type 2 diabetes mellitus.
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![Structures of soybean-derived polyphenol compounds used in this study and their α-glucosidase inhibitory activity. (**A**) Acarbose, a positive control, (**B**) glyceollin, (**C**) genistein, (**D**) luteolin, and (**E**) daidzein. Relative α-glucosidase activity (**F**) was calculated as a relative percentage of the control group. The enzyme activity was calculated as described in Materials and Methods.](biomolecules-09-00828-g001){#biomolecules-09-00828-f001}

![Non-linear regression analysis of α-glucosidase. The inhibitors were applied at the indicated concentrations: (**A**) Acarbose, (**B**) glyceollin, (**C**) genistein, (**D**) luteolin, and (**E**) daidzein. A mixture of 100 μL of each concentration of *p*-nitrophenyl α-D-glucopyranoside (pNPG) was added to 96-well plates that contained polyphenols and treated with α-glucosidase to initiate the enzyme reaction. The Lineweaver--Burk plots show the enzyme kinetics of the four kinds of classical inhibition modes. Each plot represents the results from three independent experiments.](biomolecules-09-00828-g002){#biomolecules-09-00828-f002}

![Modes of α-glucosidase inhibition for polyphenols derived from soybeans. To calculate the mode of action, Lineweaver--Burk plots were constructed: (**A**) Acarbose (closed triangle, 100 μM; open square, 300 μM; closed diamond, 1000 μM; open circle, 3000 μM), (**B**) glyceollin (closed triangle, 1 μM; open square, 3 μM; closed diamond, 10 μM; open circle, 30 μM), (**C**) genistein (closed triangle, 1 μM; open square, 3 μM; closed diamond, 10 μM; open circle, 30 μM), (**D**) luteolin (closed triangle, 1 μM; open square, 3 μM; closed diamond, 10 μM; open circle, 30 μM), and (**E**) daidzein (closed triangle, 1 μM; open square, 3 μM; closed diamond, 10 μM; open circle, 30 μM).](biomolecules-09-00828-g003){#biomolecules-09-00828-f003}

![Molecular docking studies on the modes of α-glucosidase inhibition. The model of MAL12, a structure of α-glucosidase, is shown as a cartoon or surface diagram in white. Isomaltose, acarbose, glyceollin, genistein, luteolin, and daidzein are shown as stick diagrams. (**A**) The inhibitory mode of acarbose. The isomaltose molecule was prepared by superposing the model of MAL12 with the structure of isomaltase (PDB code 3AXH) and is shown in cyan. Residues involved in substrate binding are displayed as stick models. Yellow dashed lines indicate hydrogen bond interactions. The glucosidic bonds to be hydrolyzed are indicated by a star. (**B**--**E**) The inhibitory modes of polyphenols. Glyceollin, genistein, luteolin, and daidzein are shown as stick diagrams in magenta, purple, yellow, and brown, respectively.](biomolecules-09-00828-g004){#biomolecules-09-00828-f004}

![Synergistic effect of glyceollin plus luteolin on α-glucosidase inhibition. Glyceollin and luteolin were each prepared as 2 μM solutions and mixed in ratios ranging from 0:10 to 10:0. Therefore, a 5:5 ratio indicates mixture of 1 μM glyceollin plus 1 μM luteolin. (**A**) The pattern of α-glucosidase inhibition according to four concentrations of substrate (0.5, 1, 1.5, and 2 mM). (**B**) Lineweaver--Burk plots of the effects of glyceollin plus luteolin mixtures at various ratios. (**C**) Combination index (CI) plot of various ratios of glyceollin and luteolin. The CI--isobologram equation permits quantitative determination of compound interactions and CI \< 1, CI = 1, and CI \> 1 show synergism, an additive effect, and antagonism, respectively.](biomolecules-09-00828-g005){#biomolecules-09-00828-f005}

biomolecules-09-00828-t001_Table 1

###### 

*K~i~* values of polyphenols derived from soybeans for α-glucosidase inhibition. *K~i~* values of acarbose, glyceollin, genistein, luteolin, and daidzein were calculated using GraphPad Prism 6.0 software. For daidzein, an α*K~i~* value is provided instead of a *K~i~* value.

  Inhibitor    Mode of Inhibition   *K~m~* (μm)   *K~i~* (μm)
  ------------ -------------------- ------------- --------------
  Acarbose     Competitive          0.21 ± 0.02   45.88 ± 3.75
  Glyceollin   Competitive          0.24 ± 0.03   18.99 ± 4.45
  Genistein    Noncompetitive       0.36 ± 0.06   15.42 ± 2.48
  Luteolin     Mixed                0.30 ± 0.06   16.81 ± 9.60
  Daidzein     Uncompetitive        0.40 ± 0.05   9.99 ± 1.24
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Synergistic effects of glyceollin in combination with three polyphenols derived from soybeans on α-glucosidase inhibition.

  IC~50~                        Mode of Inhibition   Substrate (PNPG, mM)   Remark                                                        
  ----------------------------- -------------------- ---------------------- --------------------- --------------------- ----------------- -----------------
  Glyceollin (μM)               Competitive          16.57 ± 3.25           16.57 ± 0.15          19.11 ± 0.96          33.23 ± 3.97      Synergistic
  Luteolin (μM)                 Mixed                18.63 ± 1.20           14.82 ± 0.01          15.35 ± 1.99          19.52 ± 1.59      
  Glyceollin + Luteolin (μM)    　                   6.31 ± 0.59 \*^,\#^    6.78 ± 0.18 \*^,\#^   9.00 ± 0.40 \*^,\#^   14.16 ± 0.35 \*   
  Glyceollin (μM)               Competitive          16.57 ± 3.25           16.57 ± 0.15          19.11 ± 0.96          33.23 ± 3.97      Non-synergistic
  Genistein (μM)                Noncompetitive       40.47 ± 4.99           15.42 ± 0.33          12.00 ± 0.31          9.10 ± 0.61       
  Glyceollin + Genistein (μM)   　                   32.47 ± 1.48           33.73 ± 1.51          20.67 ± 0.44          21.81 ± 0.58      
  Glyceollin (μM)               Competitive          16.57 ± 3.25           16.57 ± 0.15          19.11 ± 0.96          33.23 ± 3.97      Non-synergistic
  Daidzein (μM)                 Uncompetitive        59.16 ± 6.10           27.56 ± 2.93          23.19 ± 1.04          20.53 ± 1.82      
  Glyceollin + Daidzein (μM)                         33.69 ± 0.65           22.78 ± 1.20          16.05 ± 0.51          19.04 ± 0.08      

\* *p* \< 0.05: Combination treatment is significantly different from glyceollin alone. *^\#^ p* \< 0.05: Combination treatment is significantly different from luteolin alone.
